)
Medikit (7749) investor relations material
Medikit Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Net sales rose 8.1% year-over-year to ¥6,365 million for the quarter ended June 30, 2026, with operating profit up 23.8% to ¥1,266 million and profit attributable to owners of parent up 33.5% to ¥523 million.
Comprehensive income nearly doubled year-over-year, reaching ¥588 million, reflecting strong operational and financial performance.
Financial highlights
Gross profit increased to ¥2,456 million from ¥2,218 million year-over-year, with gross margin improving.
Operating profit margin improved, with operating profit before goodwill amortization at ¥1,320 million, up 22.6% year-over-year.
Basic earnings per share rose to ¥36.15 from ¥26.83 year-over-year.
Total assets stood at ¥52,855 million and net assets at ¥46,645 million as of June 30, 2026.
Outlook and guidance
Full-year net sales forecast at ¥25,800 million, up 8.5% year-over-year, with operating profit expected to rise 0.6% to ¥4,300 million.
Profit attributable to owners of parent projected to decline 5.2% to ¥2,850 million for the fiscal year ending March 31, 2027.
No revisions to previously announced earnings or dividend forecasts.
- Revenue up 4.1% but profits down; strong balance sheet and ongoing investment in growth.7749
Q1 2025 - Revenue up 4.1% year-over-year, but profit margins declined amid rising costs and market shifts.7749
Q2 2025 - Revenue up 2.9% year-over-year, but profit outlook remains cautious amid industry headwinds.7749
Q3 2025 - Sales rose 3.2% YoY, but profits dipped; FY2026 outlook sees higher sales and dividends.7749
Q4 2025 - Sales and profits rose modestly, with strong cash flow and higher dividends forecast.7749
Q2 2026 - Sales rose but profits slipped; full-year outlook sees stable sales and strong financial position.7749
Q1 2026 - Sales up 5.4% YoY, profits slightly down, strong cash flow, and higher comprehensive income.7749
Q4 2026 - Nine-month sales and profits rose, with full-year guidance showing steady sales but lower profit.7749
Q3 2026
Next Medikit earnings date
Next Medikit earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage